Nothing Special   »   [go: up one dir, main page]

NL185343C - Gevormde farmaceutische preparaten met antilipemische ontstekingswerende en immuniteitregelende werking en daarvoor geschikte sulfonaatverbindingen en een bereidingswijze. - Google Patents

Gevormde farmaceutische preparaten met antilipemische ontstekingswerende en immuniteitregelende werking en daarvoor geschikte sulfonaatverbindingen en een bereidingswijze.

Info

Publication number
NL185343C
NL185343C NLAANVRAGE8100494,A NL8100494A NL185343C NL 185343 C NL185343 C NL 185343C NL 8100494 A NL8100494 A NL 8100494A NL 185343 C NL185343 C NL 185343C
Authority
NL
Netherlands
Prior art keywords
antilipemic
immunity
inflammatory
preparation
pharmaceutical preparations
Prior art date
Application number
NLAANVRAGE8100494,A
Other languages
English (en)
Dutch (nl)
Other versions
NL8100494A (nl
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1121480A external-priority patent/JPS6059904B2/ja
Priority claimed from JP9529980A external-priority patent/JPS5721321A/ja
Priority claimed from JP55137026A external-priority patent/JPS5759854A/ja
Priority claimed from JP55180852A external-priority patent/JPS57102858A/ja
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of NL8100494A publication Critical patent/NL8100494A/nl
Application granted granted Critical
Publication of NL185343C publication Critical patent/NL185343C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/64Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/68Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a carbon skeleton substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/71Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/74Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of six-membered aromatic rings being part of condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/75Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing singly-bound oxygen atoms bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/76Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • C07C309/72Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/77Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE8100494,A 1980-01-31 1981-02-02 Gevormde farmaceutische preparaten met antilipemische ontstekingswerende en immuniteitregelende werking en daarvoor geschikte sulfonaatverbindingen en een bereidingswijze. NL185343C (nl)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP1121480 1980-01-31
JP1121480A JPS6059904B2 (ja) 1980-01-31 1980-01-31 スルホネ−ト誘導体およびその製造方法
JP9529980A JPS5721321A (en) 1980-07-11 1980-07-11 Antihyperlipemic agent
JP9529980 1980-07-11
JP55137026A JPS5759854A (en) 1980-09-30 1980-09-30 Sulfonate derivative and its preparation
JP13702680 1980-09-30
JP55180852A JPS57102858A (en) 1980-12-19 1980-12-19 Sulfonate derivative
JP18085280 1980-12-19

Publications (2)

Publication Number Publication Date
NL8100494A NL8100494A (nl) 1981-09-01
NL185343C true NL185343C (nl) 1990-03-16

Family

ID=27455558

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE8100494,A NL185343C (nl) 1980-01-31 1981-02-02 Gevormde farmaceutische preparaten met antilipemische ontstekingswerende en immuniteitregelende werking en daarvoor geschikte sulfonaatverbindingen en een bereidingswijze.

Country Status (9)

Country Link
US (2) US4411911A (fr)
AU (1) AU527933B2 (fr)
CA (1) CA1167046A (fr)
CH (1) CH655098A5 (fr)
DE (1) DE3103144A1 (fr)
ES (1) ES8201964A1 (fr)
FR (1) FR2475041A1 (fr)
GB (1) GB2068371B (fr)
NL (1) NL185343C (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452813A (en) * 1981-05-22 1984-06-05 Taiho Pharmaceutical Company Limited Sulfonate derivatives, process for preparing same and antilipemic compositions containing the derivative
DE3368259D1 (en) * 1982-09-06 1987-01-22 Taiho Pharmaceutical Co Ltd Sulfonic ester derivatives and process for their preparation
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
US5484777A (en) * 1989-04-20 1996-01-16 Lange, Iii; Louis G. Pancreatic cholesterol esterase inhibitor
US5017565A (en) * 1989-04-20 1991-05-21 Lange Iii Louis G Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
CN109020847B (zh) * 2018-09-18 2021-03-02 苏州大学张家港工业技术研究院 一种制备全氟烷基亚磺酸酯的方法
WO2020056653A1 (fr) * 2018-09-19 2020-03-26 苏州大学张家港工业技术研究院 Procédé de préparation d'un ester de perfluoroalkylsulfinate
CN112661675B (zh) * 2021-01-07 2022-10-21 中国科学院青岛生物能源与过程研究所 一种α-羰基磺酸酯的合成方法及其使用的催化剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA617957A (en) * 1961-04-11 Paabo George O-(phenylsulphonyl) glycolyl anilides and a process using them
US2845448A (en) * 1954-10-26 1958-07-29 R G Taylor Company Inc Aromatic sulfonic acid esters of mandelic acid for inhibition of enzymes
US3200138A (en) * 1962-04-09 1965-08-10 Warner Lambert Pharmaceutical Mesyloxyacetic acid and acid chloride
DE2060551A1 (de) * 1970-12-09 1972-06-22 Bayer Ag Neue aliphatische difunktionelle stickstoffhaltige Sulfonsaeureester,ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CH563356A5 (fr) * 1972-05-17 1975-06-30 Esteve Dr Lab Del Sa
DE2431734A1 (de) * 1974-07-02 1976-01-29 Basf Ag Beta-ketopropan-sultone und -sultame

Also Published As

Publication number Publication date
AU6667781A (en) 1981-08-06
US4489091A (en) 1984-12-18
CH655098A5 (de) 1986-03-27
AU527933B2 (en) 1983-03-31
DE3103144C2 (fr) 1992-11-12
CA1167046A (fr) 1984-05-08
US4411911A (en) 1983-10-25
ES499527A0 (es) 1982-02-01
GB2068371B (en) 1983-11-30
GB2068371A (en) 1981-08-12
FR2475041A1 (fr) 1981-08-07
DE3103144A1 (de) 1981-11-26
NL8100494A (nl) 1981-09-01
FR2475041B1 (fr) 1984-12-28
ES8201964A1 (es) 1982-03-16

Similar Documents

Publication Publication Date Title
NL187352C (nl) Farmaceutisch preparaat, alsmede sulfonzuurester van een 2-oxoalkanol derivaat.
IS1307B6 (is) Aðferð til að framleiða lyfjablöndu
IT1153315B (it) Preparazioni di insulina stabilizzate e un procedimento per la loro preparazione
DK460283A (da) Fremgangsmaade til fremstilling af topiske farmaceutiske praeparater
NL930033I1 (nl) 7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-naftyridine-3-carbonzuren werkwijzen ter bereiding ervan en deze bevattende geneesmiddelen
NL930065I2 (nl) 3-Aminoalkyl-1H-indool-5-methaansulfonamideverbinding en farmaceutisch preparaat met halsslagader-vernauwende werking.
PT73686A (pt) Pharmaceutical formulation
FI812810L (fi) Ammoniometylfoereningar farmaceutiska preparat innehaollande dessa foereningar och anvaendning av sistnaemnda
FI92053B (fi) Analogiamenetelmä uuden lääkkeen valmistamiseksi
FI812811L (fi) N-oxider av n-oxacyklyl-alkylpiperidiner foerfarande foer deras framstaellning dessa foereningar innehaollande farmaceutiska preparat och deras anvaendning
FI822187L (fi) Farmaceutiska preparat
FI783861A (fi) Tandskyddande vattenfattiga sockerhaltiga livsmedel och tandskyddande vattenfattiga farmaceutiska preparat
NL185343C (nl) Gevormde farmaceutische preparaten met antilipemische ontstekingswerende en immuniteitregelende werking en daarvoor geschikte sulfonaatverbindingen en een bereidingswijze.
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
FI832467L (fi) Difosfonsyraderivat och dessa innehaollande farmaceutiska preparat
IS1678B (is) Aðferð til framleiðslu á lyfjablöndu gegn hálskirtlabólgu
DK314283D0 (da) Farmaceutiske praeparater
NL7802525A (nl) Vast farmaceutisch preparaat en werkwijze ter bereiding daarvan.
DK413279A (da) Fremgangsmaade til fremstilling af natriumamoxicillin og injicerbare natriumamoxicillin-dosispraeparater og herved vundne praeparater
MC1372A1 (fr) Preparations pharmaceutiques
DK47681A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK228381A (da) Fremgangsmaade til fremstilling af antidiarretiske farmaceutiske praeparater
FI823690L (fi) Aminocyklopentanestrar och deras framstaellning och farmaceutiska preparat
FI783860A (fi) Tandskyddande vattenfattiga sockerhaltiga livsmedel och tandskyddande vattenfattiga farmaceutiska preparat
ES522904A0 (es) Un metodo para obtener una preparacion farmaceutica que contiene un derivado de 16 beta-etil-17 beta-hidroxi-estrano.

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee

Effective date: 19960901